SurgaColl Technologies Ltd:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:SurgaColl Technologies Ltd - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C10465
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アイルランド
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
SurgaColl Technologies Ltd (SurgaColl Technologies) is a medical device company that develops novel tissue regeneration products for the surgical treatment of disease of the bone, cartilage and other human tissue. The company’s products include hydroxycoll and chondrocoll. Its hydroxycoll is a bone graft substitute that helps the body to create, own natural healing process from bioactive materials. SurgaColl Technologies’ hydroxycoll scaffold is a bioactive and biodegradable matrix that is optimized to facilitate and promote bone tissue healing. The company offers chondrocoll, a biomimetic and bioactive layered scaffold for use in the regeneration and repair of osteochondral defects, such as trauma and osteoarthritis. SurgaColl Technologies is headquartered in Dublin, Ireland.

SurgaColl Technologies Ltd – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
SurgaColl Technologies Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
SurgaColl Technologies Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 6
SurgaColl Technologies Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
SurgaColl Technologies Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
SurgaColl Technologies Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
SurgaColl Technologies Ltd, Medical Equipment, Deal Details 10
Venture Financing 10
SurgaColl Technologies Raises USD4.2 Million in Series A Financing 10
SurgaColl Technologies to Raise up to USD3.3 Million in Financing Round 11
SurgaColl Technologies Raises US$2.5 Million In Venture Financing 12
SurgaColl Technologies Ltd – Key Competitors 13
SurgaColl Technologies Ltd – Key Employees 14
SurgaColl Technologies Ltd – Locations And Subsidiaries 15
Head Office 15
Recent Developments 16
Corporate Communications 16
Jan 16, 2017: SurgaColl Technologies: Board Announcement – Appointment of CEO 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
SurgaColl Technologies Ltd, Medical Equipment, Key Facts 2
SurgaColl Technologies Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
SurgaColl Technologies Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
SurgaColl Technologies Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 6
SurgaColl Technologies Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
SurgaColl Technologies Ltd, Deals By Market, 2012 to YTD 2018 8
SurgaColl Technologies Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
SurgaColl Technologies Raises USD4.2 Million in Series A Financing 10
SurgaColl Technologies to Raise up to USD3.3 Million in Financing Round 11
SurgaColl Technologies Raises US$2.5 Million In Venture Financing 12
SurgaColl Technologies Ltd, Key Competitors 13
SurgaColl Technologies Ltd, Key Employees 14

List of Figures
SurgaColl Technologies Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
SurgaColl Technologies Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
SurgaColl Technologies Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
SurgaColl Technologies Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
SurgaColl Technologies Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
SurgaColl Technologies Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
SurgaColl Technologies Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
SurgaColl Technologies Ltd, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[SurgaColl Technologies Ltd:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • ET Solar Group Corporation:企業の戦略的SWOT分析
    ET Solar Group Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • BBB Technologies Inc:製品パイプライン分析
    Summary BBB Technologies Inc (BBB Tech) is a development stage medical technology company, which develops devices and applications that facilitate the early diagnosis of metabolic and cardiovascular disorders. It develops single-drop, mobile integrated diagnostic tools for blood testing. Its lead pr …
  • PGE Polska Grupa Energetyczna SA (PGE):電力:M&Aディール及び事業提携情報
    Summary PGE Polska Grupa Energetyczna SA (PGE SA) is a state owned energy utility. It generates, trades, transmits, and distributes electricity. The company carries out lignite mining activities, electricity generation from fossil fuels (lignite, hard coal, and natural gas) and renewable energy sour …
  • Qualcomm Inc (QCOM):企業の財務・戦略的SWOT分析
    Qualcomm Inc (QCOM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • HiberGene Diagnostics Ltd:医療機器:M&Aディール及び事業提携情報
    Summary HiberGene Diagnostics Ltd (HiberGene Diagnostics) is a medical equipment company that manufactures, develops and markets molecular diagnostic tests for human infectious diseases using the LAMP technology. The company’s products include HG C. Difficile, HG Meningococcus, HG Group B Streptococ …
  • Carl Zeiss AG:医療機器:M&Aディール及び事業提携情報
    Summary Carl Zeiss AG (Carl Zeiss) is a medical technology with focus on optical and optoelectronic industry. It develops and distributes lithography optics, measuring technology, photomask systems, microscopes, medical technology products including ophthalmic diagnostic and therapeutic products, ey …
  • Amarin Corp Plc (AMRN):企業の財務・戦略的SWOT分析
    Amarin Corp Plc (AMRN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Linde AG:企業の戦略・SWOT・財務分析
    Linde AG - Strategy, SWOT and Corporate Finance Report Summary Linde AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Mizuho Trust & Banking Co Ltd:企業の戦略・SWOT・財務情報
    Mizuho Trust & Banking Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Mizuho Trust & Banking Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • North Carolina Biotechnology Center-製薬・医療分野:企業M&A・提携分析
    Summary North Carolina Biotechnology Center (NCBiotech) is a life-science service provider that offers economic development services. The organization provides hamner conference center, office space for rent, and biotech business library services. It offers meeting space, catering, rooms and service …
  • Public Power Corporation SA (PPC):企業の財務・戦略的SWOT分析
    Public Power Corporation SA (PPC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • AgeneBio Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary AgeneBio Inc (AgeneBio) is a pharmaceutical company that develops therapies for psychiatric and neurological diseases. The company’s therapy is targeted to prevent neurodegeneration and preserve and restore cognitive function for unserved patients. Its lead candidate AGB101 is under phase 3 …
  • SAE Towers Holdings LLC:企業の戦略的SWOT分析
    SAE Towers Holdings LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • IACInterActiveCorp (IAC):企業の財務・戦略的SWOT分析
    IACInterActiveCorp (IAC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Nippon Shinyaku Co Ltd (4516):企業の財務・戦略的SWOT分析
    Nippon Shinyaku Co Ltd (4516) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Achelios Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Achelios Therapeutics Inc (Achelios) is a pharmaceutical company that develops therapeutics for the treatment of pain and inflammation by topically delivered medications. The company’s lead products include Topofen, a product for the indication of acute migraine, prophylactic migraine, osteo …
  • Statkraft AS:電力:M&Aディール及び事業提携情報
    Summary Statkraft AS (Statkraft), a subsidiary of Statkraft SF, is a power utility which produces electricity and supplies district heating. It generates power from hydro, wind, gas, solar and bio-power sources. The company develops hydroelectric power plants in emerging markets outside Europe. Stat …
  • Duro Felguera SA (MDF):企業の財務・戦略的SWOT分析
    Duro Felguera SA (MDF) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Hoegh LNG Holdings Ltd (HLNG):企業の財務・戦略的SWOT分析
    Summary Hoegh LNG Holdings Ltd (Hoegh LNG), formerly known as Leif Hoegh & Co Ltd is an oil and gas company that offers floating energy solutions. The company's services include floating storage and regasification unit solutions, in-house ship management, floating LNG energy services, LNG regasifica …
  • ImmunoGen Inc (IMGN):製薬・医療:M&Aディール及び事業提携情報
    Summary ImmunoGen Inc (ImmunoGen) is a clinical-stage biotechnology company that focuses on the development of antibody-drug conjugate therapies for the treatment of cancer. The company’s lead product candidate, mirvetuximab soravtansine, a folate receptor alpha (FRa) intended for the treatment of p …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆